Skip to main content
OpenTrials

Clinical trial condition

Systemic Lupus Erythematosus

Explore clinical trials studying Systemic Lupus Erythematosus. Study availability and eligibility vary by location and protocol.

495 public trials 114 recruiting studies
Refine in advanced search Browse all conditions

Systemic Lupus Erythematosus trial results

Recruiting

A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)

NCT07409181

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +3 more
Locations
  • Wallace & Lee Center Beverly Hills, California, United States
  • Arthritis & Osteoporosis Medical Center, Inc - La Palma La Palma, California, United States
  • University of California San Diego San Diego, California, United States
  • University of California Los Angeles Torrance, California, United States
View all 140 locations
View Trial Details
Recruiting

A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions and Subcutaneous Injections of ABBV-519 in Adult Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA)

NCT07607964

Conditions
Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +9 more
Locations
  • Pinnacle Research Group /ID# 278677 Anniston, Alabama, United States
  • Solace Research /ID# 279155 Tustin, California, United States
  • Clinical Research Of West Florida - Phase I Unit /ID# 279292 Clearwater, Florida, United States
  • Finlay Medical Research - Greenacres /ID# 278380 Greenacres City, Florida, United States
View Trial Details
Recruiting

A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus

NCT06617325

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +3 more
Locations
  • Sl0044 50058 Avondale, Arizona, United States
  • Sl0044 50550 Chandler, Arizona, United States
  • Sl0044 50713 Gilbert, Arizona, United States
  • Sl0044 50662 Glendale, Arizona, United States
View all 242 locations
View Trial Details
Recruiting

A Study of LY4298445 in Healthy Participants and Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA)

NCT07276958

Conditions
Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +10 more
Locations
  • Nucleus Network Brisbane, Australia
  • Nucleus Network Melbourne, Australia
  • Peking University First Hospital Beijing, China
  • Peking University Third Hospital Beijing, China
View Trial Details
Recruiting

A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus Nephritis

NCT07570862

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +15 more
Locations
  • Wallace Rheumatic Studies Center Beverly Hills, California, United States
  • Providence Medical Foundation Fullerton, California, United States
  • Miami Dermatology and Laser Research Miami, Florida, United States
  • University of Nebraska Medical Center Omaha, Nebraska, United States
View Trial Details
Recruiting

A Clinical Study of MK-1045 in People With Lupus or Rheumatoid Arthritis (MK-1045-004)

NCT07363590

Conditions
Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +9 more
Locations
  • Gold Coast University Hospital ( Site 1601) Southport, Queensland, Australia
  • Anima Diepenbeek ( Site 0601) Diepenbeek, Limburg, Belgium
  • UZ Gent ( Site 0602) Ghent, Oost-Vlaanderen, Belgium
  • Chinese Academy of Medical Science Peking Union Medical College Hospital ( Site 1501) Beijing, Beijing Municipality, China
View all 20 locations
View Trial Details
Recruiting

A Study to Assess the Safety and PK/PD of LBL-047 in Healthy Adults and Patients With Systemic Lupus Erythematosus

NCT07323173

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +3 more
Locations
  • The First Affiliated Hospital of Bengbu Medical University Bengbu, Anhui, China
  • Sun Yat-sen Memorial Hospital, Sun Yat-sen University Guangzhou, Guangdong, China
  • Xiangya School of Medicine of Central South University Changsha, Hunan, China
  • Nanjing Drum Tower Hospital Nanjing, Jiangsu, China
View Trial Details
Recruiting

RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus

NCT06121297

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +12 more
Locations
  • University of California Irvine Orange, California, United States
  • UC Davis Health Sacramento, California, United States
  • Yale University New Haven, Connecticut, United States
  • University of Florida Health Gainesville, Florida, United States
View all 23 locations
View Trial Details

Related conditions